Cancer incidence in patients with schizophrenia and their first‐degree relatives – a meta‐analysis
Authors:
- 10 March 2008
- journal article
- research article
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 117 (5) , 323-336
Abstract
Objective: Controversy concerning cancer incidence in schizophrenia exists because of heterogeneous study findings.Method: A meta‐analysis was performed on standardized incidence ratios (SIR) of cancer in patients with schizophrenia and first‐degree relatives and compared with general population samples.Results: The pooled overall cancer incidence in patients was not significantly increased (SIR = 1.05, CI 0.95–1.15). Lung cancer incidence was slightly increased (SIR = 1.31, CI 1.01–1.71), but was reduced after adjusting for smoking prevalence. The incidence of several cancers unrelated to smoking was reduced in patients. Breast cancer rates were significantly increased in female patients. The pooled overall cancer incidence in siblings (SIR = 0.89, CI 0.84–0.94) and parents (SIR = 0.90, CI 0.88–0.93) was significantly reduced. A meta‐regression detected a significant relationship between cancer risk in the general population and relative risk in patients.Conclusion: The meta‐analysis aided exploration of inconsistent study findings. There is a discrepancy between cancer risk exposure and cancer incidence in schizophrenia consistent with a protective effect.Keywords
This publication has 59 references indexed in Scilit:
- Prolactin and breast cancer riskCancer Letters, 2006
- Medical comorbidity in women and men with schizophreniaJournal of General Internal Medicine, 2006
- Cancer risk among users of neuroleptic medication: a population-based cohort studyBritish Journal of Cancer, 2006
- The effect of lifestyle factors on gynaecological cancerBest Practice & Research Clinical Obstetrics & Gynaecology, 2006
- Reduced cancer incidence among patients with schizophreniaCancer, 2005
- Cancer in schizophrenia: is the risk higher or lower?Schizophrenia Research, 2005
- Apoptosis and schizophrenia: is the tumour suppressor gene, p53, a candidate susceptibility gene?Schizophrenia Research, 2000
- Medical Comorbidity in SchizophreniaSchizophrenia Bulletin, 1996
- The occurence of cancer in first admitted schizophrenic patientsSchizophrenia Research, 1994
- Mortality and Causes of Death in First Admitted Schizophrenic PatientsThe British Journal of Psychiatry, 1993